|
Feb 4
|
Five Upcoming Class Actions for Investors to Know About
|
|
Jan 9
|
UPDATE 2-BioNTech predicts return to revenue growth in 2025
|
|
Jan 9
|
Midday movers: Boeing, CrowdStrike and more
|
|
Jan 9
|
BioNTech predicts return to revenue growth in 2025
|
|
Jan 9
|
BioNTech expects 2024 revenues of about $3.3 bln
|
|
Jan 9
|
BioNTech Outlines 2024 Strategic Priorities at the 42nd Annual J.P. Morgan Healthcare Conference
|
|
Dec 24
|
15 Undervalued Defensive Stocks For 2024
|
|
Dec 21
|
BioNTech and DualityBio Receive FDA Breakthrough Therapy Designation for Antibody-Drug Conjugate Candidate BNT323/DB-1303 in Endometrial Cancer
|
|
Dec 19
|
Why Is COVID-19 Vaccine Player CureVac Stock Plummeting Today?
|
|
Dec 19
|
UPDATE 2-German court quashes CureVac patent after challenge by BioNTech
|
|
Dec 18
|
BioNTech Achieves Milestone at mRNA-based Vaccine Manufacturing Site in Rwanda
|
|
Dec 18
|
BioNTech aims to start mRNA vaccine output in Rwanda in 2025
|
|
Dec 18
|
3 Stocks Down 30% or More This Year That Wall Street Expects to Skyrocket in 2024
|
|
Dec 8
|
12 Best Healthcare Stocks For the Long-Term
|
|
Dec 5
|
Do You Think the Decrease in Demand for COVID-19 Vaccine Boosters Impacted BioNTech SE (BNTX)?
|
|
Dec 1
|
BioNTech ADRs drop after JPMorgan lowers outlook to "underweight"
|
|
Nov 28
|
AWS expands big pharma partnerships in manufacturing, AI, and R&D
|
|
Aug 31
|
Pfizer (PFE) & BioNTech Get CHMP Nod for Updated Covid-19 Jab
|
|
Aug 30
|
Pfizer and BioNTech Receive Positive CHMP Opinion for Omicron XBB.1.5-adapted COVID-19 Vaccine in the European Union
|
|
Aug 30
|
UPDATE 2-EU regulators backs Pfizer's updated vaccine for dominant Omicron subvariant
|